Spironolactone for treatment of female pattern hair loss - 19/06/20
Doi : 10.1016/j.jaad.2020.03.087
Laura J. Burns, BS a, Brianna De Souza, MD a, Elizabeth Flynn, BS a, Dina Hagigeorges, BS a, Maryanne M. Senna, MD a, b, ⁎ 
a Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts
b Harvard Medical School, Boston, Massachusetts
∗Correspondence to: Maryanne M. Senna, MD, 50 Staniford St, Ste 200, Boston, MA 0211450 Staniford StSte 200BostonMA02114
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: Reviewed and approved by the Partners Healthcare IRB (protocol no. 2018P002473). |
|
| Reprints not available from the authors. |
© 2020
Publié par Elsevier Masson SAS.
Vol 83 - N° 1
P. 276-278 - juillet 2020 Retour au numéro
Article précédent
- Factors associated with surgical site infection of the lower extremity: A retrospective cohort study
- Neera R. Nathan, Daniel M. O'Connor, Jeffrey B. Tiger, Laura M. Sowerby, Suzanne M. Olbricht, Su Luo
- Viral reactivation in hospitalized patients with drug reaction with eosinophilia and systemic symptoms: A retrospective study from a tertiary medical center in the United States
- Nima Milani-Nejad, John Trinidad, Benjamin H. Kaffenberger
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?